# Orally Disintegrating Tablets:  Guidance for Industry - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/orally-disintegrating-tablets-guidance-for-industry/e9db30b4-68fc-445e-9286-7e4573fd1c00

> FDA guidance document: Orally Disintegrating Tablets:  Guidance for Industry. Issue date: December 16, 2008. Get complete insights and analysis.

---

## Details

- Title: Orally Disintegrating Tablets:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2008-12-16
- Last Changed: 2020-05-15
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2007-D-0365">FDA-2007-D-0365</a>

## Related Documents

- [Residual Drug in Transdermal and Related Drug Delivery Systems:  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/residual-drug-in-transdermal-and-related-drug-delivery-systems-guidance-for-industry/54698fcf-db58-4dd4-ac3a-81992e898cae)
- [Tablet Scoring:Nomenclature, Labeling, and Data for Evaluation](https://www.keypedia.com/guidances/guidance-document/tablet-scoringnomenclature-labeling-and-data-for-evaluation/d4b6bb69-1a24-4ebd-be2e-a80b08473b39)
- [Medication Guides — Adding a Toll-Free Number for Reporting Adverse Events](https://www.keypedia.com/guidances/guidance-document/medication-guides-adding-a-toll-free-number-for-reporting-adverse-events/55bf6f85-07ac-436b-bb1a-804570352668)